Jo Brewer

Jo Brewer

Company: Adaptimmune

Job title: VP, Allogeneic Research


Jo is one of the founding scientists at Adaptimmune and has been part of the evolution of the company as it has grown from 5 people to 400. She has 18 years research experience in immunology and the biotech industry, specialising in TCRs and adoptive Tcell therapy for oncology.  Currently she leads a team striving to develop an allogeneic platform creating the off-the-shelf T-cell therapies from pluripotent stem cellsPreviously she has led several research teams including next gen modifications to T-cell biology to improve T-cell therapeutic efficacy and generating T-cell clones as a source of TCR for affinity enhancement. 

Prior to joining Adaptimmune, Jo led a research team at Avidex working on small molecule inhibitors and soluble proteins for treating rheumatoid arthritis and other autoimmune diseases by blocking Tcell activity. Jo holds a PhD and MA (Natural Sciences) from the University of Cambridge, UK. 

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.